Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy

The Oncologist(2024)10.1093/oncolo/oyae110Source: DataRank Database

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy is a research paper published in The Oncologist (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: goldTopics (50)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Joanne F. Chou ORCID,Henry Walch ORCID,Fergus Keane ORCID,Danny N. Khalil ORCID,Jinru Shia ORCID

Live enrichment

PubMed:38937977 PMC:PMC11448888 OpenAlex:https://openalex.org/W38937977

NIH/NCI Cancer Center

Grant: P30-CA008748

NIBIB NIH HHS

Grant: R01 EB027498

NCI NIH HHS

Grant: U01 CA238444

NIGMS NIH HHS

Grant: T32 GM132083

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Grant: 5T32GM132083-02

Tri-Institutional PhD Program in Computational Biology and Medicine

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5U01CA238444-02

Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)

National Institutes of Health

Grant: 5R01EB027498-03

Deformation Corrected Image Guided Laparoscopic Liver Surgery

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

publisherhttps://doi.org/10.1093/oncolo/oyae110

publisherhttps://academic.oup.com/oncolo/article-pdf/29/10/894/59558408/oyae110.pdf

journalhttp://dl.acm.org/citation.cfm?id=113349.113360

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11448888/pdf/oyae110.pdf

Europe_PMChttps://europepmc.org/articles/PMC11448888

Fields of Study

Design Education and Practice0301 basic medicine0303 health sciences03 medical and health sciencesHumansCarcinoma, HepatocellularLiver NeoplasmsMaleFemaleMiddle AgedAgedRetrospective StudiesAdultImmune Checkpoint InhibitorsImmunotherapyAged, 80 and over

MeSH Terms

HumansCarcinoma, HepatocellularLiver NeoplasmsImmunotherapyRetrospective StudiesAdultAgedAged, 80 and overMiddle AgedFemaleMaleImmune Checkpoint Inhibitors

Keywords

Perspective (graphical)The artsGraphicsComputer scienceComputer graphics (images)Visual artsArtTumorImmunotherapyBiomarkersImmune Checkpoint InhibitorsMaleAdultAged, 80 and overCarcinoma, HepatocellularLiver NeoplasmsMiddle AgedHumansFemaleHepatobiliaryAgedRetrospective Studies